Skip to Main Content
QA Addressing Drug Costs Reported on Prescription Drug Events (PDEs)

Please see the attached memo from Abby L. Block, Director, Center for Beneficiary Choices, that extends the deadline for Part D plans to request an opportunity to update their bids based on a misunderstanding of CMS's policy on reporting costs on PDEs. Thank you.